Skip to main content
Premium Trial:

Request an Annual Quote

Spiral Genetics Completes $3M Series A Round, Partners with Omicia

NEW YORK (GenomeWeb News) – Bioinformatics firm Spiral Genetics today announced the completion of its Series A financing that raised $3 million. It also announced a partnership with Omicia.

Venture capital firm DFJ led the round and funds will go toward the development of bioinformatics tools for the analyses of large-scale genomic data. Spiral will use the money to expand its bioinformatics engineering team, scale its sales and marketing efforts, and accelerate product development, it said.

The company's cloud-based platform accelerates the data processing time from days to hours, it added, resulting in the analysis time for a whole genome at 40x coverage at about three hours.

The Seattle-based firm also announced a partnership with Omicia, which develops informatics systems for interpreting human genome sequences for research and clinical applications. The deal will leverage Omicia's Opal solution, a variant analysis tool for genome research and prioritizing disease-causing variants.

Martin Reese, co-founder, president, and CEO of Emeryville, Calif.-based Omicia, said in a statement, "Our partnership with Spiral Genetics allows faster and more accurate interpretation of human genomes for clinical relevance, a critical bottleneck for adoption of genomes into clinical care and laboratory testing.

"In combination with Omicia's Opal system, our partnership will move us closer to a seamless solution from raw sequence data to clinically relevant genomic variants. Speed and user friendliness are critical for adoption of human genome sequencing," he added.

Financial and other terms of the deal were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.